Quick Takeaways
- Jill Beraud has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $5,746,553.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Jill Beraud
- Location
- San Francisco, CA
- Summary
- The estimated net worth of Jill Beraud is at least $5,746,553 dollars as of 27 Feb 2026. Jill Beraud is the Director of LEVI STRAUSS & CO and owns shares of LEVI STRAUSS & CO (LEVI) stock worth about $5.75M.
- Signature
- /s/ Priscilla Duncan-Tannous, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jill Beraud and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: LEVI STRAUSS & CO ($5,746,553).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jill Beraud
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| LEVI | LEVI STRAUSS & CO | Director | $5,746,553 | 25 Feb 2026 | ||
| RVNC | Revance Therapeutics, Inc. | Director | $0 | 04 Feb 2025 |
Insider Transactions Reported by Jill Beraud:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.